Computational drug design targeting MYH7 for hypertrophic cardiomyopathy integrating molecular docking, Density Functional Theory, and Molecular Dynamics Simulations Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.71336/jabs.1477
Hypertrophic cardiomyopathy (HCM) is a genetic condition of the heart that is commonly associated with mutations of sarcomeric proteins such as MYH7. Currently available therapies are largely palliative and do not offer cure-focused treatment. In this work, we utilize a computational approach combining molecular docking, Density Functional Theory (DFT), and Molecular Dynamics (MD) simulations to search for therapeutic compounds interacting with the MYH7 protein. Predicted models of MYH7 by Alpha Fold provided strong prediction reliability since 91.4% of residues were in the favored Ramachandran region. Out of multiple bioactive candidates screened, thymoquinone showed the most negative free energy of binding (-6.7 kcal/mol) to MYH7. Pharmacophore modeling along with ADMET analysis also validated its druglike nature and declared safety. Analyzing electronic properties showed that thymoquinone possesses a low HOMO-LUMO band gap (~5.67 eV), thus showcasing strong bioreactivity and stability. These results provide a direction for the intervention of MYH7 protein dysfunction. Such progress would aim at changing the treatments from palliative strategies to curative approach which is particularly essential to mitigate the risk of sudden cardiac death, especially in children. However further in vitro and in vivo studies are required to validate the safety and efficiency of the thymoquinone.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.71336/jabs.1477
- https://jabsonline.org/index.php/jabs/article/download/1477/825
- OA Status
- diamond
- References
- 35
- OpenAlex ID
- https://openalex.org/W4415200869
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415200869Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.71336/jabs.1477Digital Object Identifier
- Title
-
Computational drug design targeting MYH7 for hypertrophic cardiomyopathy integrating molecular docking, Density Functional Theory, and Molecular Dynamics SimulationsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-29Full publication date if available
- Authors
-
Nimra Hanif, A. E. Arif, Shaukat Ali, Muqaddas Anees Muqaddas Anees, Mavra Anees Mavra Anees, Arooj Arshad, Muhammad AsimList of authors in order
- Landing page
-
https://doi.org/10.71336/jabs.1477Publisher landing page
- PDF URL
-
https://jabsonline.org/index.php/jabs/article/download/1477/825Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://jabsonline.org/index.php/jabs/article/download/1477/825Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
35Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415200869 |
|---|---|
| doi | https://doi.org/10.71336/jabs.1477 |
| ids.doi | https://doi.org/10.71336/jabs.1477 |
| ids.openalex | https://openalex.org/W4415200869 |
| fwci | 0.0 |
| type | article |
| title | Computational drug design targeting MYH7 for hypertrophic cardiomyopathy integrating molecular docking, Density Functional Theory, and Molecular Dynamics Simulations |
| biblio.issue | 3 |
| biblio.volume | 19 |
| biblio.last_page | 192 |
| biblio.first_page | 179 |
| topics[0].id | https://openalex.org/T10882 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Cardiomyopathy and Myosin Studies |
| topics[1].id | https://openalex.org/T10821 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9768000245094299 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Cardiovascular Function and Risk Factors |
| topics[2].id | https://openalex.org/T10913 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.9646000266075134 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2208 |
| topics[2].subfield.display_name | Electrical and Electronic Engineering |
| topics[2].display_name | Molecular Junctions and Nanostructures |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.71336/jabs.1477 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S5406978913 |
| locations[0].source.issn | 2146-0108 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2146-0108 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Applied Biological Sciences |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://jabsonline.org/index.php/jabs/article/download/1477/825 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Applied Biological Sciences |
| locations[0].landing_page_url | https://doi.org/10.71336/jabs.1477 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5093216647 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Nimra Hanif |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nimra Hanif |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5109691832 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | A. E. Arif |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Amna Arif Amna Arif |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5039741315 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2900-9995 |
| authorships[2].author.display_name | Shaukat Ali |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sadia Ali Sadia Ali |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5120005454 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Muqaddas Anees Muqaddas Anees |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Muqaddas Anees Muqaddas Anees |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5120005455 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Mavra Anees Mavra Anees |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mavra Anees Mavra Anees |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5054839360 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0562-9484 |
| authorships[5].author.display_name | Arooj Arshad |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Arooj Arshad |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5101850287 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9556-8701 |
| authorships[6].author.display_name | Muhammad Asim |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Muhammad Asim |
| authorships[6].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://jabsonline.org/index.php/jabs/article/download/1477/825 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-15T00:00:00 |
| display_name | Computational drug design targeting MYH7 for hypertrophic cardiomyopathy integrating molecular docking, Density Functional Theory, and Molecular Dynamics Simulations |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10882 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Cardiomyopathy and Myosin Studies |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.71336/jabs.1477 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S5406978913 |
| best_oa_location.source.issn | 2146-0108 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2146-0108 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Applied Biological Sciences |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://jabsonline.org/index.php/jabs/article/download/1477/825 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Applied Biological Sciences |
| best_oa_location.landing_page_url | https://doi.org/10.71336/jabs.1477 |
| primary_location.id | doi:10.71336/jabs.1477 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S5406978913 |
| primary_location.source.issn | 2146-0108 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2146-0108 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Applied Biological Sciences |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://jabsonline.org/index.php/jabs/article/download/1477/825 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Applied Biological Sciences |
| primary_location.landing_page_url | https://doi.org/10.71336/jabs.1477 |
| publication_date | 2025-09-29 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4285500649, https://openalex.org/W4403748248, https://openalex.org/W4386380000, https://openalex.org/W4321788006, https://openalex.org/W4380153758, https://openalex.org/W3211032018, https://openalex.org/W3185504655, https://openalex.org/W3179031073, https://openalex.org/W4210666396, https://openalex.org/W3147241712, https://openalex.org/W3083029037, https://openalex.org/W4281618675, https://openalex.org/W4210521381, https://openalex.org/W3101992942, https://openalex.org/W4312226310, https://openalex.org/W4392957328, https://openalex.org/W4406633314, https://openalex.org/W4399995467, https://openalex.org/W4400353742, https://openalex.org/W4413440251, https://openalex.org/W4389174567, https://openalex.org/W4390941838, https://openalex.org/W4405895616, https://openalex.org/W4404664441, https://openalex.org/W4394780513, https://openalex.org/W4409841534, https://openalex.org/W4400663423, https://openalex.org/W4406268426, https://openalex.org/W4412001692, https://openalex.org/W4401829136, https://openalex.org/W4386843650, https://openalex.org/W3163628301, https://openalex.org/W4322616995, https://openalex.org/W4315499042, https://openalex.org/W4396782736 |
| referenced_works_count | 35 |
| abstract_inverted_index.a | 4, 39, 125, 141 |
| abstract_inverted_index.In | 34 |
| abstract_inverted_index.as | 20 |
| abstract_inverted_index.at | 154 |
| abstract_inverted_index.by | 68 |
| abstract_inverted_index.do | 29 |
| abstract_inverted_index.in | 80, 177, 181, 184 |
| abstract_inverted_index.is | 3, 11, 165 |
| abstract_inverted_index.of | 7, 16, 66, 77, 86, 98, 146, 172, 195 |
| abstract_inverted_index.to | 54, 102, 161, 168, 189 |
| abstract_inverted_index.we | 37 |
| abstract_inverted_index.Out | 85 |
| abstract_inverted_index.aim | 153 |
| abstract_inverted_index.and | 28, 49, 115, 136, 183, 193 |
| abstract_inverted_index.are | 25, 187 |
| abstract_inverted_index.for | 56, 143 |
| abstract_inverted_index.gap | 129 |
| abstract_inverted_index.its | 112 |
| abstract_inverted_index.low | 126 |
| abstract_inverted_index.not | 30 |
| abstract_inverted_index.the | 8, 61, 81, 93, 144, 156, 170, 191, 196 |
| abstract_inverted_index.(MD) | 52 |
| abstract_inverted_index.Fold | 70 |
| abstract_inverted_index.MYH7 | 62, 67, 147 |
| abstract_inverted_index.Such | 150 |
| abstract_inverted_index.also | 110 |
| abstract_inverted_index.band | 128 |
| abstract_inverted_index.eV), | 131 |
| abstract_inverted_index.free | 96 |
| abstract_inverted_index.from | 158 |
| abstract_inverted_index.most | 94 |
| abstract_inverted_index.risk | 171 |
| abstract_inverted_index.such | 19 |
| abstract_inverted_index.that | 10, 122 |
| abstract_inverted_index.this | 35 |
| abstract_inverted_index.thus | 132 |
| abstract_inverted_index.vivo | 185 |
| abstract_inverted_index.were | 79 |
| abstract_inverted_index.with | 14, 60, 107 |
| abstract_inverted_index.(-6.7 | 100 |
| abstract_inverted_index.(HCM) | 2 |
| abstract_inverted_index.91.4% | 76 |
| abstract_inverted_index.ADMET | 108 |
| abstract_inverted_index.Alpha | 69 |
| abstract_inverted_index.MYH7. | 21, 103 |
| abstract_inverted_index.These | 138 |
| abstract_inverted_index.along | 106 |
| abstract_inverted_index.heart | 9 |
| abstract_inverted_index.offer | 31 |
| abstract_inverted_index.since | 75 |
| abstract_inverted_index.vitro | 182 |
| abstract_inverted_index.which | 164 |
| abstract_inverted_index.work, | 36 |
| abstract_inverted_index.would | 152 |
| abstract_inverted_index.(DFT), | 48 |
| abstract_inverted_index.(~5.67 | 130 |
| abstract_inverted_index.Theory | 47 |
| abstract_inverted_index.death, | 175 |
| abstract_inverted_index.energy | 97 |
| abstract_inverted_index.models | 65 |
| abstract_inverted_index.nature | 114 |
| abstract_inverted_index.safety | 192 |
| abstract_inverted_index.search | 55 |
| abstract_inverted_index.showed | 92, 121 |
| abstract_inverted_index.strong | 72, 134 |
| abstract_inverted_index.sudden | 173 |
| abstract_inverted_index.Density | 45 |
| abstract_inverted_index.However | 179 |
| abstract_inverted_index.binding | 99 |
| abstract_inverted_index.cardiac | 174 |
| abstract_inverted_index.favored | 82 |
| abstract_inverted_index.further | 180 |
| abstract_inverted_index.genetic | 5 |
| abstract_inverted_index.largely | 26 |
| abstract_inverted_index.protein | 148 |
| abstract_inverted_index.provide | 140 |
| abstract_inverted_index.region. | 84 |
| abstract_inverted_index.results | 139 |
| abstract_inverted_index.safety. | 117 |
| abstract_inverted_index.studies | 186 |
| abstract_inverted_index.utilize | 38 |
| abstract_inverted_index.Dynamics | 51 |
| abstract_inverted_index.analysis | 109 |
| abstract_inverted_index.approach | 41, 163 |
| abstract_inverted_index.changing | 155 |
| abstract_inverted_index.commonly | 12 |
| abstract_inverted_index.curative | 162 |
| abstract_inverted_index.declared | 116 |
| abstract_inverted_index.docking, | 44 |
| abstract_inverted_index.druglike | 113 |
| abstract_inverted_index.mitigate | 169 |
| abstract_inverted_index.modeling | 105 |
| abstract_inverted_index.multiple | 87 |
| abstract_inverted_index.negative | 95 |
| abstract_inverted_index.progress | 151 |
| abstract_inverted_index.protein. | 63 |
| abstract_inverted_index.proteins | 18 |
| abstract_inverted_index.provided | 71 |
| abstract_inverted_index.required | 188 |
| abstract_inverted_index.residues | 78 |
| abstract_inverted_index.validate | 190 |
| abstract_inverted_index.Analyzing | 118 |
| abstract_inverted_index.Currently | 22 |
| abstract_inverted_index.HOMO-LUMO | 127 |
| abstract_inverted_index.Molecular | 50 |
| abstract_inverted_index.Predicted | 64 |
| abstract_inverted_index.available | 23 |
| abstract_inverted_index.bioactive | 88 |
| abstract_inverted_index.children. | 178 |
| abstract_inverted_index.combining | 42 |
| abstract_inverted_index.compounds | 58 |
| abstract_inverted_index.condition | 6 |
| abstract_inverted_index.direction | 142 |
| abstract_inverted_index.essential | 167 |
| abstract_inverted_index.kcal/mol) | 101 |
| abstract_inverted_index.molecular | 43 |
| abstract_inverted_index.mutations | 15 |
| abstract_inverted_index.possesses | 124 |
| abstract_inverted_index.screened, | 90 |
| abstract_inverted_index.therapies | 24 |
| abstract_inverted_index.validated | 111 |
| abstract_inverted_index.Functional | 46 |
| abstract_inverted_index.associated | 13 |
| abstract_inverted_index.candidates | 89 |
| abstract_inverted_index.efficiency | 194 |
| abstract_inverted_index.electronic | 119 |
| abstract_inverted_index.especially | 176 |
| abstract_inverted_index.palliative | 27, 159 |
| abstract_inverted_index.prediction | 73 |
| abstract_inverted_index.properties | 120 |
| abstract_inverted_index.sarcomeric | 17 |
| abstract_inverted_index.showcasing | 133 |
| abstract_inverted_index.stability. | 137 |
| abstract_inverted_index.strategies | 160 |
| abstract_inverted_index.treatment. | 33 |
| abstract_inverted_index.treatments | 157 |
| abstract_inverted_index.interacting | 59 |
| abstract_inverted_index.reliability | 74 |
| abstract_inverted_index.simulations | 53 |
| abstract_inverted_index.therapeutic | 57 |
| abstract_inverted_index.Hypertrophic | 0 |
| abstract_inverted_index.Ramachandran | 83 |
| abstract_inverted_index.cure-focused | 32 |
| abstract_inverted_index.dysfunction. | 149 |
| abstract_inverted_index.intervention | 145 |
| abstract_inverted_index.particularly | 166 |
| abstract_inverted_index.thymoquinone | 91, 123 |
| abstract_inverted_index.Pharmacophore | 104 |
| abstract_inverted_index.bioreactivity | 135 |
| abstract_inverted_index.computational | 40 |
| abstract_inverted_index.thymoquinone. | 197 |
| abstract_inverted_index.cardiomyopathy | 1 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.67112698 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |